Unknown

Dataset Information

0

Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells.

ABSTRACT:

SUBMITTER: Xiong D 

PROVIDER: S-EPMC10958673 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Mitochondria-targeted atovaquone promotes anti-lung cancer immunity by reshaping tumor microenvironment and enhancing energy metabolism of anti-tumor immune cells.

Xiong Donghai D   Yin Zheng Z   Huang Mofei M   Wang Yian Y   Hardy Micael M   Kalyanaraman Balaraman B   Wong Stephen T ST   You Ming M  

Cancer communications (London, England) 20231106 3

Similar Datasets

Unknown Vascular normalization: reshaping the tumor microenvironment and augmenting antitumor immunity for ovarian cancer.
| S-EPMC10626545 | biostudies-literature
Unknown High Salt Inhibits Tumor Growth by Enhancing Anti-tumor Immunity.
| S-EPMC6557976 | biostudies-literature
Unknown Potent inhibition of tumour cell proliferation and immunoregulatory function by mitochondria-targeted atovaquone.
| S-EPMC7578061 | biostudies-literature
Unknown YIV-906 potentiated anti-PD1 action against hepatocellular carcinoma by enhancing adaptive and innate immunity in the tumor microenvironment.
| S-EPMC8242098 | biostudies-literature
Unknown Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity.
| S-EPMC8064125 | biostudies-literature
Unknown Mitochondria-Targeted Nanoadjuvants Induced Multi-Functional Immune-Microenvironment Remodeling to Sensitize Tumor Radio-Immunotherapy.
| S-EPMC11234464 | biostudies-literature
Unknown Histone lactylation regulates cancer progression by reshaping the tumor microenvironment.
| S-EPMC10641494 | biostudies-literature
Unknown Virus-stimulated neutrophils in the tumor microenvironment enhance T cell-mediated anti-tumor immunity.
| S-EPMC5173127 | biostudies-literature
Unknown Targeting IRE1α reprograms the tumor microenvironment and enhances anti-tumor immunity in prostate cancer.
| S-EPMC11480464 | biostudies-literature
Unknown CD38 contributes to tumor progression and tumor microenvironment reshaping in epithelial ovarian cancer.
| S-EPMC12143800 | biostudies-literature